描述
Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.
Figure 30
Source Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 30: Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled." /> <figcaption>Figure 30. Summary statistics and final outcome measures from the synbiotic preparation trial in diarrhea-predominant IBS are compiled.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
相关证据
B
Bifidobacterium longum 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 4 项研究
Galactooligosaccharides (GOS) 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 3 项研究
Lactobacillus acidophilus 用于 Irritable Bowel Syndrome (IBS)
D
等级 B · 3 项研究
Fructooligosaccharides (FOS) 用于 Irritable Bowel Syndrome (IBS)
等级 D · 2 项研究